AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
Q1 2023 | $115 | -91.4% | 396 | -86.7% | 0.00% | – |
Q4 2022 | $1,335 | -99.8% | 2,968 | +88.4% | 0.00% | – |
Q3 2022 | $828,000 | -68.9% | 1,575 | -70.1% | 0.00% | – |
Q2 2022 | $2,661,000 | -67.7% | 5,269 | +47.2% | 0.00% | – |
Q1 2022 | $8,234,000 | -84.5% | 3,580 | -67.9% | 0.00% | – |
Q4 2021 | $53,005,000 | -38.0% | 11,159 | +3.7% | 0.00% | – |
Q3 2021 | $85,510,000 | +161.1% | 10,756 | +128.6% | 0.00% | – |
Q2 2021 | $32,747,000 | -40.6% | 4,705 | -32.4% | 0.00% | – |
Q1 2021 | $55,123,000 | -20.5% | 6,960 | -21.0% | 0.00% | – |
Q4 2020 | $69,335,000 | -1.7% | 8,810 | -11.4% | 0.00% | – |
Q3 2020 | $70,510,000 | +294.4% | 9,945 | +414.5% | 0.00% | – |
Q2 2020 | $17,880,000 | -52.5% | 1,933 | -76.1% | 0.00% | – |
Q1 2020 | $37,620,000 | +52.7% | 8,073 | +150.4% | 0.00% | – |
Q4 2019 | $24,631,000 | -7.2% | 3,224 | -6.6% | 0.00% | – |
Q3 2019 | $26,554,000 | +77.9% | 3,453 | +58.5% | 0.00% | – |
Q2 2019 | $14,926,000 | -54.0% | 2,179 | -46.0% | 0.00% | – |
Q1 2019 | $32,458,000 | +536.3% | 4,032 | +656.5% | 0.00% | – |
Q3 2018 | $5,101,000 | -9.5% | 533 | 0.0% | 0.00% | – |
Q2 2018 | $5,639,000 | – | 533 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $532,000 | 6.17% |
Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |